As of 2024-12-12, the EV/EBITDA ratio of Ikena Oncology Inc (IKNA) is -0.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IKNA's latest enterprise value is 47.68 mil USD. IKNA's TTM EBITDA according to its financial statements is -62.96 mil USD. Dividing these 2 quantities gives us the above IKNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 36.8x - 46.3x | 46.0x |
| Forward P/E multiples | 36.8x - 50.4x | 46.0x |
| Fair Price | (41.58) - (52.51) | (52.19) |
| Upside | -2546.1% - -3188.8% | -3169.8% |
| Date | EV/EBITDA |
| 2024-12-02 | -0.78 |
| 2024-11-29 | -0.78 |
| 2024-11-27 | -0.75 |
| 2024-11-26 | -0.77 |
| 2024-11-25 | -0.77 |
| 2024-11-22 | -0.77 |
| 2024-11-21 | -0.78 |
| 2024-11-20 | -0.76 |
| 2024-11-19 | -0.74 |
| 2024-11-18 | -0.74 |
| 2024-11-15 | -0.75 |
| 2024-11-14 | -0.77 |
| 2024-11-13 | -0.79 |
| 2024-11-12 | -0.81 |
| 2024-11-11 | -0.80 |
| 2024-11-08 | -0.81 |
| 2024-11-07 | -0.75 |
| 2024-11-06 | -0.77 |
| 2024-11-05 | -0.75 |
| 2024-11-04 | -0.77 |
| 2024-11-01 | -0.77 |
| 2024-10-31 | -0.77 |
| 2024-10-30 | -0.76 |
| 2024-10-29 | -0.77 |
| 2024-10-28 | -0.77 |
| 2024-10-25 | -0.77 |
| 2024-10-24 | -0.77 |
| 2024-10-23 | -0.75 |
| 2024-10-22 | -0.75 |
| 2024-10-21 | -0.75 |
| 2024-10-18 | -0.77 |
| 2024-10-17 | -0.77 |
| 2024-10-16 | -0.77 |
| 2024-10-15 | -0.77 |
| 2024-10-14 | -0.77 |
| 2024-10-11 | -0.77 |
| 2024-10-10 | -0.77 |
| 2024-10-09 | -0.77 |
| 2024-10-08 | -0.76 |
| 2024-10-07 | -0.75 |
| 2024-10-04 | -0.76 |
| 2024-10-03 | -0.73 |
| 2024-10-02 | -0.74 |
| 2024-10-01 | -0.76 |
| 2024-09-30 | -0.78 |
| 2024-09-27 | -0.78 |
| 2024-09-26 | -0.77 |
| 2024-09-25 | -0.76 |
| 2024-09-24 | -0.76 |
| 2024-09-23 | -0.75 |